Brooklyn ImmunoTherapeutics (NYSE:BTX) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report released on Thursday morning. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Down 8.8 % Shares of BTX opened at $1.76 on Thursday. The firm has a 50-day moving average price of $2.24 and a […]

Related Keywords

Brooklyn Immunotherapeutics ,Brooklyn Immunotherapeutics Company Profile ,Exchange Commission ,Brooklyn Immunotherapeutics Inc ,Eterna Therapeutics Inc ,Renaissance Technologies ,Free Report ,Get Free Report ,Nyse Btx ,Kbtx ,Information ,Initiated Coverage ,Stocknews Com ,